Abstract |
We describe herein the current concepts tested in clinical trials dedicated to patients with metastatic soft tissue sarcomas: identify predictive factors under anthracyclin-based regimens, identify patients beneficing from polychemotherapy, benefit of maintenance treatment, use of non-progression rate rather than response rate for selecting new drugs, histology-tailored or biological target-tailored second-line treatment.
|
Authors | N Penel, F Watelle, M Vanhuyse, A Adenis |
Journal | Bulletin du cancer
(Bull Cancer)
Vol. 97
Issue 6
Pg. 687-91
(Jun 2010)
ISSN: 1769-6917 [Electronic] France |
Vernacular Title | Traitement des sarcomes des tissus mous de l'adulte métastatiques: évolution actuelle des concepts. |
PMID | 20462829
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- ridaforolimus
- Doxorubicin
- Sirolimus
|
Topics |
- Adult
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Doxorubicin
(administration & dosage)
- Humans
- Sarcoma
(drug therapy, pathology, secondary)
- Sirolimus
(administration & dosage, analogs & derivatives)
- Soft Tissue Neoplasms
(drug therapy, pathology)
|